Olokizumab, a new drug for managing rheumatoid arthritis
Despite the recent therapeutic advances, nearly 25% of patients are refractory to the treatment regimens. The findings of an international multi-centre study led by MedUni Vienna, published in the New England Journal of Medicine, have reported olokizumab as a newer treatment option with promising results for the management of RA. Olokizumab, the humanized monoclonal antibody, … Read more